The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 29, 2025

Filed:

Aug. 13, 2021
Applicant:

Rhythm Pharmaceuticals, Inc., Boston, MA (US);

Inventors:

Shubh Sharma, Cranbury, NJ (US);

Leonardus H. T. Van Der Ploeg, Newton, MA (US);

Bart T. Henderson, Belmont, MA (US);

Assignee:

RHYTHM PHARMACEUTICALS, INC., Boston, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/12 (2005.12); A61K 9/08 (2005.12); A61K 9/10 (2005.12); A61K 9/14 (2005.12); A61K 38/08 (2018.12); A61K 45/06 (2005.12); A61K 47/10 (2016.12); A61K 47/12 (2005.12); A61K 47/24 (2005.12); A61K 47/38 (2005.12); A61K 47/54 (2016.12);
U.S. Cl.
CPC ...
A61K 38/12 (2012.12); A61K 9/08 (2012.12); A61K 9/10 (2012.12); A61K 9/146 (2012.12); A61K 38/08 (2012.12); A61K 45/06 (2012.12); A61K 47/10 (2012.12); A61K 47/12 (2012.12); A61K 47/24 (2012.12); A61K 47/38 (2012.12); A61K 47/541 (2017.07); A61K 47/542 (2017.07); A61K 47/544 (2017.07);
Abstract

The present invention relates to an ionic complex comprising a cationic polypeptide and an anionic excipient selected from: a PEG-carboxylic acid; a fatty acid having 10 or more carbon atoms; an anionic phospholipid; and a combination thereof. The invention also relates to a pharmaceutical composition comprising the ionic complex of the invention and a pharmaceutically acceptable carrier. The cationic polypeptide of the ionic complex has pharmacological activity and the complex can provide a more desirable pharmacokinetic profile for the cationic polypeptide of the complex as compared to the cationic polypeptide alone following administration. As such, the invention also relates to the use of the ionic complex and pharmaceutical composition comprising same to treat a subject suffering from a disease or disorder that is responsive to the cationic polypeptide of the ionic complex.


Find Patent Forward Citations

Loading…